Softwr

Healthcare · head to head

athenaOne vs Lunit

athenaOne logo

athenaOne

Healthcare

Unified cloud platform combining EHR, practice management, and patient engagement

From
$250/month
Rated
-
Lunit logo

Lunit

Healthcare

FDA cleared and CE marked AI for mammography, tomosynthesis and chest radiography

From
On request
Rated
-

The short version

  • Each has a real cost: athenaOne no published pricing on homepage, pricing available through request for demo only; Lunit the regulatory permission differs by product and by region, and INSIGHT Risk has been filed with the FDA but not cleared, so a buyer who reads a corporate press release rather than the specific clearance for their product and jurisdiction will plan a deployment they cannot legally run.
  • They diverge on capability: athenaOne covers Electronic Health Records, Lunit covers Lunit INSIGHT MMG.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which athenaOne and Lunit actually diverge.

Attributes where athenaOne and Lunit differ
AttributeathenaOneLunit
Starting price$250/monthOn request
Pricing modelsubscriptionquote
PlatformsWeb, Mobile, ApiWeb
Founded1997Unknown

Identical on both: free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in athenaOne

  • Electronic Health Records
  • Practice Management
  • Patient Engagement
  • Care Coordination
  • Analytics
  • Mobile App
  • Telehealth
  • Labs

Only in Lunit

  • Lunit INSIGHT MMG
  • Lunit INSIGHT DBT
  • Lunit INSIGHT CXR
  • Volpara density assessment
  • Volpara RiskPathways
  • Volpara dose tracking
  • PACS and mammography workstation integration

What people use each for

The jobs each tool is most often brought in to do.

athenaOne

  • Patient Carenot Lunit
  • Medical Recordsnot Lunit
  • Practice Managementnot Lunit
  • Telehealthnot Lunit

Lunit

  • A national breast screening programme evaluating AI as a second reader to reduce double reading workload where two human readers are currently mandatednot athenaOne
  • A breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on DBT specificallynot athenaOne
  • An American breast imaging centre needing automated volumetric density assessment to meet patient density notification requirements, which is what Volpara is bought fornot athenaOne
  • A tuberculosis or lung screening programme in a high volume, radiologist scarce setting using chest radiography triage to prioritise filmsnot athenaOne

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

athenaOne

  • No published pricing on homepage, pricing available through request for demo only
  • Healthcare EHR systems typically require enterprise-level contracts

Lunit

  • The regulatory permission differs by product and by region, and INSIGHT Risk has been filed with the FDA but not cleared, so a buyer who reads a corporate press release rather than the specific clearance for their product and jurisdiction will plan a deployment they cannot legally run.
  • Detection AI changes recall rates in screening, and the downstream cost of additional diagnostic workup lands on the programme rather than on the software budget, which is the cost most screening business cases omit.
  • Performance is sensitive to the mammography vendor and acquisition protocol, so published results from a Hologic estate do not transfer to a GE or Siemens estate without local validation the buyer must fund.
  • MMG, DBT and CXR are licensed separately and Volpara modules are separate again, so a breast centre wanting detection, density and risk pathways is assembling four line items rather than buying one product.
  • Using AI as a replacement for one of two human readers is a workforce and liability decision that regulators and professional bodies treat differently in each country, so the saving that justifies the purchase may not be permitted where you operate.

Pricing, plan by plan

athenaOne

$250/month

No published plan breakdown. See the athenaOne review.

Lunit

On request
  • Lunit INSIGHT$undefined/year
    • Priced per study or per annual examination volume by product
    • MMG, DBT and CXR licensed separately
    • Volpara density and RiskPathways modules quoted separately

Which should you pick?

Choose athenaOne if

  • You need electronic health records.
  • You work on Web, Mobile, Api.
  • You also want practice management.

Choose Lunit if

  • You need lunit insight mmg.
  • You also want lunit insight dbt.

Questions people ask

Is athenaOne or Lunit better?
Neither clearly leads. athenaOne starts at $250/month and Lunit at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, athenaOne or Lunit?
athenaOne starts at $250/month and Lunit at On request.
Does athenaOne or Lunit run on more platforms?
athenaOne runs on Web, Mobile, Api. Lunit runs on Web.
What is athenaOne best used for?
athenaOne is most often used for patient care, medical records, practice management, telehealth. Of those, patient care and medical records are not what Lunit is typically brought in for.
What can athenaOne do that Lunit cannot?
athenaOne covers Electronic Health Records, Practice Management, Patient Engagement, Care Coordination. Lunit covers Lunit INSIGHT MMG, Lunit INSIGHT DBT, Lunit INSIGHT CXR, Volpara density assessment.

Answered from the vendors’ own pages

athenaOne: What does athenaOne cost?

athenaOne does not publish pricing on their website. Organizations must contact their sales team or schedule a demo to receive a customized quote based on practice size, specialty, and required features.

Source
Lunit: Is Lunit FDA cleared?

Yes for specific products. INSIGHT MMG, INSIGHT DBT and INSIGHT CXR Triage hold FDA 510(k) clearances. INSIGHT Risk, the five year risk prediction model, has been filed but was not cleared at the time of writing.

Lunit: Can Lunit replace a second human reader in screening?

That depends entirely on your jurisdiction and professional body guidance, not on the software. The CE mark permits clinical use; it does not authorise a workforce model.

Lunit: What did the Volpara acquisition add?

Volumetric breast density measurement, dose tracking and RiskPathways high risk programme management, which are the things American breast centres buy for density notification compliance rather than for detection.

Lunit: Is pricing published?

No. It is quoted per study or per annual volume, by product, with on premises and cloud priced differently.

Share

Related pages

Other head to heads